No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:178012800-178016600 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr5:178012800-178016800 |
Weak transcription |
Gastric |
stomach
|
3 |
chr5:178013200-178016000 |
Weak transcription |
Pancreas |
Pancrea
|
4 |
chr5:178014200-178016600 |
Bivalent Enhancer |
Fetal Heart |
heart
|
5 |
chr5:178014600-178018000 |
Flanking Active TSS |
Cortex derived primary cultured neurospheres |
brain
|
6 |
chr5:178014800-178016000 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
7 |
chr5:178014800-178016200 |
Bivalent Enhancer |
Monocytes-CD14+_RO01746 |
blood
|
8 |
chr5:178014800-178016600 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
9 |
chr5:178015000-178016000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
10 |
chr5:178015000-178016600 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
11 |
chr5:178015000-178016600 |
Enhancers |
Left Ventricle |
heart
|
12 |
chr5:178015200-178016400 |
Bivalent Enhancer |
Stomach Smooth Muscle |
stomach
|
13 |
chr5:178015600-178016600 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
14 |
chr5:178015600-178016800 |
Flanking Active TSS |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
15 |
chr5:178015600-178017800 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr5:178015800-178016000 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
17 |
chr5:178015800-178016000 |
Bivalent Enhancer |
H9 Cell Line |
embryonic stem cell
|
18 |
chr5:178015800-178016000 |
Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
19 |
chr5:178015800-178016000 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
20 |
chr5:178015800-178016000 |
Bivalent Enhancer |
Brain Dorsolateral Prefrontal Cortex |
brain
|
21 |
chr5:178015800-178016200 |
Flanking Bivalent TSS/Enh |
HUES48 Cell Line |
embryonic stem cell
|
22 |
chr5:178015800-178016200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
23 |
chr5:178015800-178016200 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
24 |
chr5:178015800-178016200 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
25 |
chr5:178015800-178016400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
26 |
chr5:178015800-178016400 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
27 |
chr5:178015800-178016400 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
28 |
chr5:178015800-178016400 |
Bivalent/Poised TSS |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
29 |
chr5:178015800-178016600 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
30 |
chr5:178015800-178016600 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
31 |
chr5:178015800-178016800 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
32 |
chr5:178015800-178016800 |
Flanking Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
33 |
chr5:178015800-178016800 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
34 |
chr5:178015800-178017200 |
Bivalent/Poised TSS |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
35 |
chr5:178015800-178017200 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
36 |
chr5:178015800-178017800 |
Flanking Active TSS |
Right Ventricle |
heart
|